McKesson Corporation Acquires Controlling Interest in Core Ventures
June 3, 2025
McKesson Corporation completed the acquisition of an approximate 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for about $2.49 billion. The venture was established by Florida Cancer Specialists & Research Institute (FCS), whose physicians retained an approximate 30% interest; FCS remains independently owned and joins McKesson's The US Oncology Network to strengthen community-based oncology care and expand access to clinical development and local cancer services.
- Buyers
- McKesson Corporation
- Targets
- Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures)
- Sellers
- Florida Cancer Specialists & Research Institute (FCS) / FCS physicians
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
NovaQuest Private Equity Acquires CoreRx, Inc.
January 19, 2021
Pharmaceuticals
NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, Florida–based contract development and manufacturing organization (CDMO). Affiliates of Signet Healthcare Partners will retain a minority stake; Goldman Sachs Specialty Lending Group provided debt financing. NovaQuest said the investment will support continued growth and capability expansion of CoreRx's clinical and commercial CDMO services.
-
Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment
May 9, 2022
Healthcare Services
Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.
-
CoreRx, Inc. Acquires Societal CDMO, Inc.
April 8, 2024
Pharmaceuticals
CoreRx, Inc. completed its acquisition of Societal CDMO, Inc. through a tender offer and subsequent short-form merger, acquiring approximately 92.8% of outstanding shares at $1.10 per share. Societal CDMO is now a wholly owned subsidiary of CoreRx and its common stock will be delisted from the Nasdaq Capital Market.
-
McKesson Acquires Controlling Interest in PRISM Vision from Quad‑C
April 8, 2025
Healthcare Services
McKesson Corporation acquired an approximate 80% controlling interest in PRISM Vision Holdings, LLC from Quad‑C Management for about $850 million, with PRISM physicians retaining roughly 20%. PRISM Vision is a regional ophthalmology and retina management platform operating 91 offices, seven ambulatory surgery centers and more than 180 providers; the deal expands McKesson’s clinical services and ophthalmology capabilities.
-
Ovation Healthcare (Grant Avenue-backed) Acquires MedCo Services
March 21, 2023
Healthcare Services
Ovation Healthcare (fka QHR Health), a hospital management and consulting company backed by Grant Avenue Capital, has acquired MedCo Services. The undisclosed deal expands Ovation’s revenue cycle management (RCM) capabilities, adds MedCo’s acute-care hospital clients and internally developed workflow software, and diversifies Ovation’s RCM technology and service offering.
-
FFL Partners and Two Sigma Impact Acquire Majority Ownership of Community Medical Services
December 21, 2021
Healthcare Services
FFL Partners and Two Sigma Impact have acquired majority ownership of Community Medical Services (CMS), a Scottsdale-based provider of medication-assisted treatment for opioid use disorder. The transaction (financial terms undisclosed) transfers majority control from Clearview Capital Fund III and is supported by senior secured financing arranged by Antares to fund CMS' continued growth and expansion across multiple states.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.